• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烧伤患者中的耐多药革兰氏阴性菌。

Multidrug-Resistant Gram-Negative Bacteria in Burn Patients.

机构信息

Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA.

Department of Surgery, University of North Carolina, Chapel Hill, North Carolina, USA.

出版信息

Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0068822. doi: 10.1128/aac.00688-22. Epub 2022 Sep 6.

DOI:10.1128/aac.00688-22
PMID:36066237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9487463/
Abstract

Patients with burn injuries are at high risk for infectious complications, and infections are the most common cause of death after the first 72 h of hospitalization. Hospital-acquired infections caused by multidrug resistant (MDR) Gram-negative bacteria (GNB) in this population are concerning. Here, we evaluated carriage with MDR GNB in patients in a large tertiary-care burn intensive care unit. Twenty-nine patients in the burn unit were screened for intestinal carriage. Samples were cultured on selective media. Median time from admission to the burn unit to first sample collection was 9 days (IQR 5 - 17 days). In 21 (72%) patients, MDR GNB were recovered; the most common bacterial species isolated was Pseudomonas aeruginosa, which was found in 11/29 (38%) of patients. Two of these patients later developed bloodstream infections with P. aeruginosa. Transmission of KPC-31-producing ST22 Citrobacter freundii was detected. Samples from two patients grew genetically similar C. freundii isolates that were resistant to ceftazidime-avibactam. On analysis of whole-genome sequencing, was part of a Tn transposon that was present on two different plasmids in each C. freundii isolate. Plasmid curing experiments showed that removal of both copies of was required to restore susceptibility to ceftazidime-avibactam. In summary, MDR GNB colonization is common in burn patients and patient-to-patient transmission of highly resistant GNB occurs. These results emphasize the ongoing need for infection prevention and antimicrobial stewardship efforts in this highly vulnerable population.

摘要

烧伤患者感染并发症的风险很高,感染是烧伤后住院前 72 小时内死亡的最常见原因。该人群中由耐多药(MDR)革兰氏阴性菌(GNB)引起的医院获得性感染令人担忧。在这里,我们评估了大型三级烧伤重症监护病房患者的 MDR GNB 携带情况。对烧伤病房的 29 名患者进行了肠道携带检测。对样本进行了选择性培养。从烧伤病房入院到第一次采样的中位时间为 9 天(IQR 5-17 天)。在 21 名(72%)患者中回收了 MDR GNB;分离出的最常见细菌是铜绿假单胞菌,在 29 名患者中的 11 名(38%)中发现了这种细菌。其中两名患者后来发生了铜绿假单胞菌血流感染。检测到携带 KPC-31 的产 ST22 弗氏柠檬酸杆菌的传播。两名患者的样本均生长出对头孢他啶-阿维巴坦耐药的遗传相似弗氏柠檬酸杆菌分离株。全基因组测序分析表明,位于两个不同质粒上的 Tn 转座子上存在。质粒消除实验表明,需要去除两个拷贝的才能恢复对头孢他啶-阿维巴坦的敏感性。总之,烧伤患者中 MDR GNB 定植很常见,并且高度耐药的 GNB 会在患者之间传播。这些结果强调了在这个高度脆弱的人群中持续需要进行感染预防和抗菌药物管理工作。

相似文献

1
Multidrug-Resistant Gram-Negative Bacteria in Burn Patients.烧伤患者中的耐多药革兰氏阴性菌。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0068822. doi: 10.1128/aac.00688-22. Epub 2022 Sep 6.
2
Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.2011年至2015年在美国医疗中心住院治疗肺炎的患者中分离出的革兰氏阴性菌对头孢他啶-阿维巴坦的抗菌活性
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02083-16. Print 2017 Apr.
3
Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections.头孢他啶/阿维巴坦聚焦:耐多药革兰氏阴性菌感染的新选择。
J Antimicrob Chemother. 2016 Oct;71(10):2713-22. doi: 10.1093/jac/dkw239. Epub 2016 Jul 17.
4
Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.头孢他啶-阿维巴坦:一种用于治疗耐药革兰氏阴性菌的新型头孢菌素/β-内酰胺酶抑制剂组合
Clin Ther. 2016 Mar;38(3):431-44. doi: 10.1016/j.clinthera.2016.01.018. Epub 2016 Mar 2.
5
Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital.头孢洛扎他唑巴坦、头孢他啶-阿维巴坦和头孢地尔在德国一所大学医院分离的多重耐药铜绿假单胞菌中的抗菌活性。
Microbiol Spectr. 2022 Oct 26;10(5):e0169722. doi: 10.1128/spectrum.01697-22. Epub 2022 Oct 3.
6
Clinical outcomes of intensive care unit patients infected with multidrug-resistant gram-negative bacteria treated with ceftazidime/avibactam and ceftolozane/tazobactam.接受头孢他啶/阿维巴坦和头孢洛扎/他唑巴坦治疗的耐多药革兰氏阴性菌感染重症监护病房患者的临床结局
Braz J Microbiol. 2024 Mar;55(1):333-341. doi: 10.1007/s42770-023-01193-x. Epub 2023 Dec 22.
7
Detection of carbapenemases bla-bla-bla-bla and extended-spectrum-β-lactamase bla-bla-bla genes in Gram-negative bacterial isolates from ICU burns patients.检测 ICU 烧伤患者革兰氏阴性细菌分离株中的 bla-bla-bla-bla 碳青霉烯酶基因和 bla-bla-bla-bla 扩展谱β-内酰胺酶基因。
Ann Clin Microbiol Antimicrob. 2022 May 19;21(1):18. doi: 10.1186/s12941-022-00510-w.
8
High oral carriage of multidrug resistant Gram-negative bacilli in adolescents: the SOPKARD-Junior study.青少年中耐多药革兰氏阴性杆菌的高口腔携带率:SOPKARD-Junior 研究。
Front Cell Infect Microbiol. 2023 Nov 16;13:1265777. doi: 10.3389/fcimb.2023.1265777. eCollection 2023.
9
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.头孢地尔:一种具有抗碳青霉烯类和多药耐药革兰氏阴性杆菌活性的铁载体头孢菌素。
Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2.
10
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.头孢他啶/阿维巴坦对重症监护病房(ICU)和非 ICU 患者的革兰氏阴性菌进行了测试,包括呼吸机相关性肺炎患者。
Int J Antimicrob Agents. 2015 Jul;46(1):53-9. doi: 10.1016/j.ijantimicag.2015.02.022. Epub 2015 Apr 14.

引用本文的文献

1
Infected burn wound healing using Hydroxy-propyl-methyl cellulose gel containing bacteriophages against and .使用含有针对[具体细菌1]和[具体细菌2]的噬菌体的羟丙基甲基纤维素凝胶促进感染烧伤创面愈合。
Iran J Microbiol. 2025 Feb;17(1):69-79. doi: 10.18502/ijm.v17i1.17803.
2
Gram-Negative Bacilli Blood Stream Infection in Patients with Severe Burns: Microbiological and Clinical Evidence from a 9-Year Cohort.革兰氏阴性杆菌血流感染严重烧伤患者:一项 9 年队列的微生物学和临床证据。
Int J Mol Sci. 2024 Sep 28;25(19):10458. doi: 10.3390/ijms251910458.
3
Epidemiology and timing of infectious complications from battlefield-related burn injuries.战场相关烧伤的感染并发症的流行病学及发生时间
Burns. 2024 Dec;50(9):107200. doi: 10.1016/j.burns.2024.07.004. Epub 2024 Jul 8.
4
Antiseptic management of critical wounds: differential bacterial response upon exposure to antiseptics and first insights into antiseptic/phage interactions.关键伤口的抗菌管理:消毒剂暴露后细菌的差异反应及抗菌/噬菌体相互作用的初步见解。
Int J Surg. 2024 Sep 1;110(9):5374-5384. doi: 10.1097/JS9.0000000000001605.
5
Multidrug-Resistant Organisms: The Silent Plight of Burn Patients.多重耐药菌:烧伤患者的无声苦难。
J Burn Care Res. 2024 Aug 6;45(4):877-886. doi: 10.1093/jbcr/irae075.
6
Evolution of Microbial Flora Colonizing Burn Wounds during Hospitalization in Uruguay.乌拉圭住院期间烧伤创面定植微生物菌群的演变
Biomedicines. 2023 Oct 26;11(11):2900. doi: 10.3390/biomedicines11112900.
7
Phenotypic and molecular characterization of beta-lactam resistant Multidrug-resistant Enterobacterales isolated from patients attending six hospitals in Northern Nigeria.尼日利亚北部六家医院就诊患者中分离出的耐β-内酰胺的多药耐药肠杆菌科的表型和分子特征。
Sci Rep. 2023 Jun 26;13(1):10306. doi: 10.1038/s41598-023-37621-z.
8
When silver doesn't shine anymore: The threat of increasing resistance to antibiotics and silver antiseptics.当银不再闪耀:抗生素及银基防腐剂耐药性增加的威胁。
New Microbes New Infect. 2023 Mar 29;52:101126. doi: 10.1016/j.nmni.2023.101126. eCollection 2023 Mar.
9
Panomics to decode virulence and fitness in Gram-negative bacteria.全基因组学解析革兰氏阴性菌的毒力和适应性
Front Cell Infect Microbiol. 2022 Nov 21;12:1061596. doi: 10.3389/fcimb.2022.1061596. eCollection 2022.

本文引用的文献

1
The BioWipe: a non-invasive method to detect intestinal carriage of multi-drug resistant GRAM-negative bacteria.生物擦拭法:一种检测多重耐药革兰氏阴性菌肠道携带情况的非侵入性方法。
J Chemother. 2022 May;34(3):203-205. doi: 10.1080/1120009X.2021.2008643. Epub 2021 Nov 26.
2
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.不同全球地区患者中耐碳青霉烯类肺炎克雷伯菌的临床结局和细菌特征(CRACKLE-2):一项前瞻性、多中心、队列研究。
Lancet Infect Dis. 2022 Mar;22(3):401-412. doi: 10.1016/S1473-3099(21)00399-6. Epub 2021 Nov 9.
3
AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence.AMRFinderPlus 和参考基因目录有助于研究抗生素耐药性、应激反应和毒力之间的基因组联系。
Sci Rep. 2021 Jun 16;11(1):12728. doi: 10.1038/s41598-021-91456-0.
4
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).美国传染病学会关于治疗产超广谱β-内酰胺酶肠杆菌科(ESBL-E)、碳青霉烯类耐药肠杆菌科(CRE)和治疗困难的耐药铜绿假单胞菌(DTR-P. aeruginosa)的指导意见。
Clin Infect Dis. 2021 Apr 8;72(7):1109-1116. doi: 10.1093/cid/ciab295.
5
Long-term contamination of sink drains by carbapenemase-producing Enterobacterales in three intensive care units: characteristics and transmission to patients.三家重症监护病房中产生碳青霉烯酶的肠杆菌科细菌对水槽排水管道的长期污染:特征及向患者的传播
J Hosp Infect. 2021 Jun;112:16-20. doi: 10.1016/j.jhin.2021.02.016. Epub 2021 Feb 23.
6
ResFinder 4.0 for predictions of phenotypes from genotypes.ResFinder 4.0 用于基因型到表型的预测。
J Antimicrob Chemother. 2020 Dec 1;75(12):3491-3500. doi: 10.1093/jac/dkaa345.
7
CRISPR-Cas9-Mediated Carbapenemase Gene and Plasmid Curing in Carbapenem-Resistant .CRISPR-Cas9 介导的碳青霉烯酶基因和质粒在碳青霉烯类耐药菌中的消除。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.00843-20.
8
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.美国碳青霉烯类耐药肠杆菌科细菌(CRACKLE-2)的分子和临床流行病学:一项前瞻性队列研究。
Lancet Infect Dis. 2020 Jun;20(6):731-741. doi: 10.1016/S1473-3099(19)30755-8. Epub 2020 Mar 6.
9
Acquisition of Antibiotic-Resistant Gram-negative Bacteria in the Benefits of Universal Glove and Gown (BUGG) Cluster Randomized Trial.在通用手套和手术衣(BUGG)集群随机试验中获得耐抗生素革兰氏阴性菌。
Clin Infect Dis. 2021 Feb 1;72(3):431-437. doi: 10.1093/cid/ciaa071.
10
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization.产碳青霉烯酶肺炎克雷伯菌引起的对头孢他啶/阿维巴坦耐药的血流感染:流行病学与基因组特征。
Clin Microbiol Infect. 2020 Apr;26(4):516.e1-516.e4. doi: 10.1016/j.cmi.2019.11.011. Epub 2019 Nov 16.